Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies

Della Makower, Alla Rozenblit, Howard Kaufman, Morris Edelman, Maureen E. Lane, James Zwiebel, Hilda Haynes, Scott Wadler

Research output: Contribution to journalArticlepeer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies'. Together they form a unique fingerprint.

Medicine & Life Sciences